Science to practice

Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?

Richard W Katzberg, John P McGahan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, Mühler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.

Original languageEnglish (US)
Pages (from-to)325-326
Number of pages2
JournalRadiology
Volume258
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Gadolinium
Magnetic Resonance Imaging
Pregnancy
Third Pregnancy Trimester
Contrast Media
Pharmacokinetics
Safety
Injections

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Science to practice : Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies? / Katzberg, Richard W; McGahan, John P.

In: Radiology, Vol. 258, No. 2, 02.2011, p. 325-326.

Research output: Contribution to journalArticle

@article{2371abcf507f4ac3bf2075c08263e147,
title = "Science to practice: Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?",
abstract = "By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, M{\"u}hler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.",
author = "Katzberg, {Richard W} and McGahan, {John P}",
year = "2011",
month = "2",
doi = "10.1148/radiol.101989",
language = "English (US)",
volume = "258",
pages = "325--326",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Science to practice

T2 - Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?

AU - Katzberg, Richard W

AU - McGahan, John P

PY - 2011/2

Y1 - 2011/2

N2 - By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, Mühler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.

AB - By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, Mühler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.

UR - http://www.scopus.com/inward/record.url?scp=79952355394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952355394&partnerID=8YFLogxK

U2 - 10.1148/radiol.101989

DO - 10.1148/radiol.101989

M3 - Article

VL - 258

SP - 325

EP - 326

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -